본문으로 바로가기

의료진 소개

류정화 의사

류정화 교수

신장내과, 투석혈관센터, 고위험 산과센터 관심의료진 등록

전문 진료 분야

신부전증, 신장염, 고혈압, 부종, 신우신염, 혈뇨, 단백뇨, 혈액/복막투석, 신장이식

진료 일정

학력사항

  • 이화여자대학교 의학박사
  • 이화여자대학교 의학석사
  • 이화여자대학교 의과대학 졸업

교육 및 연구경력

  • 2019-현재  | 이대서울병원 신장내과 교수
  • 2017-2019  | 서울대학교병원 장기이식센터 임상강사
  • 2015-2017  | 미국국립보건원(NIH) 박사후과정 연수
  • 2014  | 이화여자대학교 미생물학교실 연구전임의
  • 2011-2013  | 이화의료원 신장내과 임상조교수
  • 2008-2009  | 순천향대학교 연구 전임의
  • 2008  | 신장내과 분과전문의 취득
  • 2006-2008  | 이화의료원 신장내과 전임의
  • 2006  | 내과 전문의 취득
  • 2002-2006  | 이화의료원 내과 전공의 수료

기타 학술 관련 경력

  • 2021-현재  | 대한신장학회지 편집위원
  • 2017-현재  | 대한이식학회 정회원
  • 2017-현재  | 대한중재신장학연구회 정회원
  • 2006-현재  | 대한신장학회 정회원
  • 2001-현재  | 대한내과학회 정회원

논문

  •  Self-Reported Sleep Duration, Death-Censored Graft Failure and Health-Related Quality of Life Among Kidney Transplant Recipients: Results From the KNOW-KT Study.  Nephrology (Carlton). 2026-06. 
  •  Prevalence of polypharmacy and its association with clinical outcomes in kidney transplant recipients : results from the KNOW-KT study.  Kidney Res Clin Pract. 2026-05. 
  •  KNOW-KT Study group. KoreaN cohort study for Outcomes in patients With Kidney Transplantation (KNOW-KT): a prospective observational cohort study focusing on graft outcomes and posttransplant complications.  Clin Transplant Res. 2026-04. 
  •  KNOW-KT Study Group. KoreaN cohort study for Outcome in patients With Kidney Transplantation (KNOW-KT) study: an overview focused on cardiovascular outcomes from the Korean kidney transplant cohort.  Kidney Res Clin Pract. 2025-12. 
  •  Expanded Hemodialysis with Theranova Dialyzer and Residual Kidney Function in Patients Starting Long-Term Hemodialysis: A Randomized Controlled Trial.  J Am Soc Nephrol. 2025-05. 
  •  Impact of Blood Pressure on Allograft Function and Survival in Kidney Transplant Recipients.  Transpl Int. 2024-08. 
  •  Impact of arterial calcification on cardiovascular and renal outcomes in kidney transplant patients.  Kidney Dis (Basel). 2024-04. 
  •  Osteoprotegerin With Vascular Calcification, and Cardiovascular and Graft Outcomes in Kidney Transplantation.  Transplantation. 2024-01. 
  •  Association of Serum Activin Levels with Allograft Outcomes in Patients with Kidney Transplant: Results from the KNOW-KT.  Am J Nephrol. 2024-01. 
  •  Benefits of statin therapy within a year after kidney transplantation.  Sci Rep. 2024-01. 
  •  High pretransplant FGF23 level is associated with persistent vitamin D insufficiency and poor graft survival in kidney transplant patients.  Sci Rep. 2023-11. 
  •  Association between sclerostin levels and vascular outcomes in kidney transplantation patients.  J Nephrol. 2023-09. 
  •  Impact of iron status on kidney outcomes in kidney transplant recipients.  Scientific Reports. 2023, v.13 no.1, 861. 
  •  Early fluid management affects short-term mortality in patients with end-stage kidney disease undergoing chronic hemodialysis and requiring continuous renal replacement therapy.  BMC Nephrology. 2022, v.23 no.1, 102. 
  •  The Korean Organ Transplantation Registry (KOTRY): an overview and summary of the kidney-transplant cohort.  Kidney Research and Clinical Practice. 2022, v.41 no.4, 492-507. 
  •  Better health-related quality of life in kidney transplant patients compared to chronic kidney disease patients with similar renal function.  PLOS ONE. 2021, v.16 no.10, e0257981. 
  •  Effect of DA-9701 on the Gastrointestinal Motility in the Streptozotocin-Induced Diabetic Mice.  JOURNAL OF CLINICAL MEDICINE. 2021, v.10 no.22, 5282. 
  •  Factors Associated With Waiting Time to Deceased Donor Kidney Transplantation in Transplant Candidates.  Transplant Proc. 2018-05. 
  •  VDJ Gene Usage of B Cell Receptors in Peripheral Blood of ABO-incompatible Kidney Transplantation Patients.  Transplant Proc. 2018-05. 
  •  ApoL1 renal risk variants induce aberrant THP-1 monocyte differentiation and increase eicosanoid production via enhanced expression of cyclooxygenase-2.  Am J Physiol Renal Physiol. 2018-07. 
  •  Identification of Human B-1 Helper T Cells With a Th1-Like Memory Phenotype and High Integrin CD49d Expression.  Front Immunol. 2018-07. 
  •  The effects of indoxyl sulfate-induced endothelial microparticles on neointimal hyperplasia formation in an ex vivo model.  Ann Surg Treat Res. 2017-07. 
  •  AST-120 Improves Microvascular Endothelial Dysfunction in End-Stage Renal Disease Patients Receiving Hemodialysis.  Yonsei Med J. 2016-07. 
  •  Human tonsil‑derived mesenchymal stromal cells enhanced myelopoiesis in a mouse model of allogeneic bone marrow transplantation.  Stem Cells Dev. 2016-10. 
  •  Tonsil-derived mesenchymal stromal cells produce CXCR2-binding chemokines and acquire follicular dendritic cell-like phenotypes under TLR3 stimulation.  Cytokine. 2015-06. 
  •  Improving survival rate of Korean patients initiating dialysis.  Yonsei Med J. 2015-05. 
  •  Voice Change in End-Stage Renal Disease Patients After Hemodialysis: Correlation of Subjective Hoarseness and Objective Acoustic Parameters.  Journal of voice. 2013-11. 
  •  Clopidogrel effectively suppresses endothelial microparticle generation induced by indoxyl sulfate via inhibition of the p38 mitogen-activated protein kinase pathway.  Blood Purification . 2011-10.